Search

Eric Orlinsky, co-chair of the Firm's Corporate Practice, spoke at the Baltimore Smart Business Dealmakers Conference on June 8, 2022. Eric, a member of the Conference Host Committee, moderated a panel on the topic of "Maximizing Value in Your Sell-Side Transactions". This panel featured a group of...

MAXIMIZING VALUE IN YOUR SELL-SIDE TRANSACTIONS Eric Orlinsky, Co-Chair of the Firm's Corporate Practice, will be speaking at the Baltimore Smart Business Dealmakers Conference on June 8, 2022. Eric, a member of the Conference Host Committee, will be moderating a panel on the topic of "Maximizing...

To Correct, or to Let Stand? When high-profile figures lie about their academic records, the institutions they attended must perform a delicate balancing act between protecting their privacy and telling the truth. by Liam Knox “The hands of the institution are tied in a lot of ways from getting...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...